IRM
63
6
EQR
65
3
GME
58
6
LLY
54
-5
BA
36
-2
CAG
46
-2
HPE
14
2
JCI
47
-2
JWN
60
-4
FFIV
63
2
UNM
68
-4
NEM
61
5
JPM
64
2
FDX
57
-4
LYB
46
9
PEG
48
2
AEE
43
2
HUM
42
-6
EXC
63
-3
TXN
48
8
IRM
63
6
EQR
65
3
GME
58
6
LLY
54
-5
BA
36
-2
CAG
46
-2
HPE
14
2
JCI
47
-2
JWN
60
-4
FFIV
63
2
UNM
68
-4
NEM
61
5
JPM
64
2
FDX
57
-4
LYB
46
9
PEG
48
2
AEE
43
2
HUM
42
-6
EXC
63
-3
TXN
48
8
Financhill
Back

Cassava Sciences Quote, Financials, Valuation and Earnings

He cracked the code to crypto

Now he says a new two-year bull market has begun. And he likes one altcoin above all others.
Sell
50

SAVA
Cassava Sciences

Last Price:
20.75
Seasonality Move:
5.66%

7 Day Trial

ALL ACCESS PASS

$ 7

This DeFi Coin Could 10x Soon... I Advise You Get In Now!

Discover this DeFi diamond before the next surge

Cassava Sciences Price Quote

$20.75
+0.01 (+1.1%)
(Updated: April 25, 2024 at 6:12 AM ET)

Cassava Sciences Key Stats

Sell
50
Cassava Sciences (SAVA) is a Sell
Day range:
$20.17 - $20.84
52-week range:
$12.32 - $32.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
21.15
P/B ratio:
6.52%
Volume:
476.3K
Avg. volume:
843.7K
1-year change:
-9.15%
Market cap:
$896.5M
Revenue:
$0
EPS:
$-2.32

How Much Does Cassava Sciences Make?

Data Unavailable

Is Cassava Sciences Growing As A Company?

Data Unavailable

Cassava Sciences Stock Price Performance

  • Did Cassava Sciences Stock Go Up Last Month?
    Cassava Sciences share price went up by 4.69% last month
  • Did SAVA's Share Price Rise Over The Last Year?
    SAVA share price fell by -9.15% over the past 1 year

What Is Cassava Sciences 52-Week High & Low?

Cassava Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cassava Sciences?

  • How Much Debt Does Cassava Sciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Cassava Sciences Have?
    Cash and short term investments quarterly total is $121.1M
  • What Is Cassava Sciences’s Book Value Per Share?
    Book value per share is 3.25

Is Cassava Sciences Cash Flow Positive?

  • What Is SAVA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$82M
  • What Is Cassava Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $2.6M
  • What Is Cassava Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$414K

Cassava Sciences Return On Invested Capital

Data Unavailable

Cassava Sciences Earnings Date & Stock Price

Cassava Sciences Competitors

  • Who Are Cassava Sciences's Competitors?
    Below is a list of companies who compete with Cassava Sciences or are related in some way:
    • Amylyx Pharmaceuticals Inc (AMLX)
    • Clearside Biomedical Inc (CLSD)
    • Lantern Pharma Inc (LTRN)
    • MannKind Corp (MNKD)
    • NovaBay Pharmaceuticals Inc (NBY)

Cassava Sciences Dividend Yield

Data Unavailable

Cassava Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -25%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 124.00
Upside from Last Price: 497.88%

Major Shareholders

  • How many SAVA shares are owned by institutional investors?
    21.6M SAVA shares are owned by institutional investors
  • How many SAVA shares are owned by insiders?
    1.9M SAVA shares are owned by insiders